RAPT Therapeutics (RAPT) Insider Trading & Ownership $1.22 0.00 (-0.25%) As of 11:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RAPT Therapeutics (NASDAQ:RAPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.60%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$13.64 MNumber OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$1.30 M Get RAPT Insider Trade Alerts Want to know when executives and insiders are buying or selling RAPT Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RAPT Insider Buying and Selling by Quarter Remove Ads RAPT Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/5/2024Dirk G BrockstedtInsiderSell898$22.78$20,456.44 12/21/2023William HoInsiderSell2,500$21.68$54,200.00 11/28/2023William HoInsiderSell1,500$13.72$20,580.00 10/3/2023William HoInsiderSell2,500$15.77$39,425.00 8/18/2023William HoInsiderSell2,500$18.92$47,300.00 4/19/2023William HoInsiderSell5,000$18.88$94,400.00 3/14/2023Wendye RobbinsDirectorBuy2,500$18.99$47,475.00 3/7/2023William HoInsiderSell5,000$29.62$148,100.00 1/24/2023William HoInsiderSell5,000$30.00$150,000.00 1/19/2023William HoInsiderSell5,000$25.56$127,800.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/5/2023Dirk G BrockstedtInsiderSell742$21.97$16,301.74 12/29/2022William HoInsiderSell5,000$18.03$90,150.00 11/28/2022William HoInsiderSell5,000$17.87$89,350.00 11/2/2022William HoInsiderSell5,000$22.32$111,600.00 10/13/2022William HoInsiderSell2,000$21.52$43,040.00 8/30/2022William HoInsiderSell2,500$28.13$70,325.00 7/11/2022William HoInsiderSell2,000$19.95$39,900.00 5/25/2022Group Ii Lp ColumnMajor ShareholderBuy1,900$12.45$23,655.00 5/23/2022Group Ii Lp ColumnMajor ShareholderBuy10,236$12.50$127,950.00 5/10/2022Group Ii Lp ColumnMajor ShareholderBuy1,250,000$10.67$13,337,500.00 5/10/2022Rodney Kb YoungCFOBuy5,000$10.53$52,650.00 5/10/2022Wendye RobbinsDirectorBuy4,500$11.24$50,580.00 5/4/2022Dirk G BrockstedtInsiderSell720$15.05$10,836.00 4/11/2022Dirk G BrockstedtInsiderSell2,647$23.05$61,013.35 4/6/2022William HoInsiderSell3,000$22.96$68,880.00 (Data available from 1/1/2013 forward) RAPT Insider Trading Activity - Frequently Asked Questions Who is on RAPT Therapeutics's Insider Roster? The list of insiders at RAPT Therapeutics includes Dirk G Brockstedt, Group Ii Lp Column, Rodney Kb Young, Wendye Robbins, and William Ho. Learn more on insiders at RAPT. What percentage of RAPT Therapeutics stock is owned by insiders? 6.60% of RAPT Therapeutics stock is owned by insiders. Learn more on RAPT's insider holdings. Which RAPT Therapeutics insiders have been selling company stock? The following insiders have sold RAPT shares in the last 24 months: Dirk G Brockstedt ($20,456.44), and William Ho ($255,905.00). How much insider selling is happening at RAPT Therapeutics? Insiders have sold a total of 14,898 RAPT Therapeutics shares in the last 24 months for a total of $276,361.44 sold. RAPT Therapeutics Key ExecutivesDr. Brian Russell Wong M.D. (Age 52)Ph.D., CEO, President & Director Compensation: $861.24kMr. Rodney K. B. Young (Age 61)CFO, Principal Accounting Officer & Secretary Compensation: $616.56kDr. William Ho M.D. (Age 58)Ph.D., Chief Medical Officer Compensation: $620.32kSteve Young Ph.D.Vice President of TechnologyDr. Dirk G. Brockstedt Ph.D. (Age 55)Chief Scientific Officer Compensation: $490.25kMr. Michael ListgartenGeneral CounselMs. Gwen R. Carscadden (Age 63)Chief Human Resources Officer Dr. Paul Kassner (Age 57)Senior Vice President of Quantitative & Computational Biology Dr. David Wustrow (Age 65)Senior Vice President of Drug Discovery & Preclinical Development Ms. Jennifer NicholsonSenior Vice President of Regulatory Affairs & Quality Assurance More Insider Trading Tools from MarketBeat Related Companies CDMO Insider Ownership QURE Insider Ownership ABCL Insider Ownership CMRX Insider Ownership PRAX Insider Ownership BCAX Insider Ownership LENZ Insider Ownership PRTA Insider Ownership AVBP Insider Ownership ORGO Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:RAPT) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RAPT Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RAPT Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
